TURKISH JOURNAL OF ONCOLOGY 2007 , Vol 22 , Num 3
Pediatric Hodgkin lymphoma: epidemiologic characteristics and early treatment results in a new oncology center
Görkem AKSU1, Merdan FAYDA 1, Funda ÇORAPÇIOĞLU 2, Nagihan İNAN3, Cengiz ERÇİN4, Eviç BAŞAR2
1Kocaeli Üniversitesi Tıp Fakültesi, Radyasyon Onkolojisi Anabilim Dalı, Kocaeli
2Kocaeli Üniversitesi Tıp Fakültesi,Çocuk Sağlığı ve Hastalıkları Anabilim Dalı, Kocaeli
3Kocaeli Üniversitesi Tıp Fakültesi,Radyoloji Anabilim Dalı, Kocaeli
4Kocaeli Üniversitesi Tıp Fakültesi, Patoloji Anabilim Dalı, Kocaeli
OBJECTIVES
To evaluate patient characteristics and treatment results of pediatric patients with Hodgkin lymphoma.

METHODS
Hodgkin lymphoma patients (9 males, 4 females; mean age 9.2±3.5; range 4 to 15 years) at pediatric age group (<18 years) treated in our oncology center between 2003 and 2006 were retrospectively analyzed.

RESULTS
The most common histopathological subtype was mixed cellular type Hodgkin lymphoma (54%). Twelve patients received ABVD regimen and the remaining patient received OEPA/COPP as first-line chemotherapy. Complete response was achieved in 11 of 13 patients (84%) following the second cycle of chemotherapy. Eleven patients received involved field radiotherapy while bulky nodal regions were irradiated in 2 patients. Although radiation doses differed according to the stage and chemotherapy response the median dose was 2000 cGy (1500-3000 cGy). Four-year disease and overall survival rates were both 87.5%.

CONCLUSION
The results of combination treatment modality ragarding stage and chemotherapy response applied in our center were similar and successful as the other more experienced oncology centers. Keywords : Child; Hodgkin disease/drug therapy/pathology/radiotherapy; prognosis; retrospective studies; survival rate